{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:01:49Z","timestamp":1768737709858,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI139473"],"award-info":[{"award-number":["AI139473"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel adjuvants are highly demanded to aid in development of improved or new vaccines against existing or emerging infectious diseases. Considering commonly used Alum and MF59 adjuvants induce tissue stress and release of endogenous danger signals to mediate their adjuvant effects, physical modalities may be used to induce tissue stress and endogenous danger signal release to enhance vaccine-induced immune responses. Furthermore, physical adjuvants are less likely to induce significant systemic adverse reactions due to their localized effects. Recently we found non-invasive radiofrequency (RF) pretreatment of the skin could significantly enhance intradermal vaccine-induced immune responses in murine models that included pandemic influenza vaccine, pre-pandemic vaccine, and influenza internal antigen vaccine. It remained to be explored whether the physical RF adjuvant (RFA) could be used to boost seasonal influenza vaccination, spare vaccine doses, and induce cross-protective immunity. This study found the physical RFA could significantly enhance seasonal influenza vaccine-induced immune responses against each viral strain and robustly enhance low-dose (nanograms) H3N2 vaccine-induced immune responses and protection in murine models. RFA also induced cross-protective immunity against heterologous and heterosubtypic influenza viruses. Further studies found heat shock protein 70 (inducible endogenous danger signal) and myeloid differentiation primary response 88 adaptor played a crucial role in dose-sparing effects of RFA. These data strongly support further development of the physical RFA to boost influenza vaccination.<\/jats:p>","DOI":"10.1038\/s41598-022-25605-4","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:08:23Z","timestamp":1670526503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvant"],"prefix":"10.1038","volume":"12","author":[{"given":"Zhuofan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinliang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"25605_CR1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed, S. G., Orr, M. T. & Fox, C. B. Key roles of adjuvants in modern vaccines. Nat. Med. 19, 1597\u20131608. https:\/\/doi.org\/10.1038\/nm.3409 (2013).","journal-title":"Nat. Med."},{"key":"25605_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2017.06.005","volume":"47","author":"AS McKee","year":"2017","unstructured":"McKee, A. S. & Marrack, P. Old and new adjuvants. Curr. Opin. Immunol. 47, 44\u201351. https:\/\/doi.org\/10.1016\/j.coi.2017.06.005 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"25605_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"A Di Pasquale","year":"2015","unstructured":"Di Pasquale, A., Preiss, S., Tavares Da Silva, F. & Garcon, N. V. Vaccine adjuvants: From 1920 to 2015 and beyond. Vaccines 3, 320\u2013343. https:\/\/doi.org\/10.3390\/vaccines3020320 (2015).","journal-title":"Vaccines"},{"key":"25605_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020075","author":"Z Li","year":"2021","unstructured":"Li, Z., Zhao, Y., Li, Y. & Chen, X. Adjuvantation of influenza vaccines to induce cross-protective immunity. Vaccines https:\/\/doi.org\/10.3390\/vaccines9020075 (2021).","journal-title":"Vaccines"},{"key":"25605_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","volume":"17","author":"N Yatim","year":"2017","unstructured":"Yatim, N., Cullen, S. & Albert, M. L. Dying cells actively regulate adaptive immune responses. Nat. Rev. Immunol. 17, 262\u2013275. https:\/\/doi.org\/10.1038\/nri.2017.9 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"25605_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2215","volume":"8","author":"H Kono","year":"2008","unstructured":"Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279\u2013289. https:\/\/doi.org\/10.1038\/nri2215 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"25605_CR7","doi-asserted-by":"publisher","first-page":"35237","DOI":"10.1074\/jbc.R114.619304","volume":"289","author":"L Schaefer","year":"2014","unstructured":"Schaefer, L. Complexity of danger: The diverse nature of damage-associated molecular patterns. J. Biol. Chem. 289, 35237\u201335245. https:\/\/doi.org\/10.1074\/jbc.R114.619304 (2014).","journal-title":"J. Biol. Chem."},{"key":"25605_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0140-6736(03)14075-5","volume":"362","author":"AG Pockley","year":"2003","unstructured":"Pockley, A. G. Heat shock proteins as regulators of the immune response. Lancet 362, 469\u2013476. https:\/\/doi.org\/10.1016\/s0140-6736(03)14075-5 (2003).","journal-title":"Lancet"},{"key":"25605_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112. https:\/\/doi.org\/10.1038\/s41577-019-0215-7 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"25605_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1096\/fj.11-184556","volume":"26","author":"S Hutchison","year":"2012","unstructured":"Hutchison, S. et al. Antigen depot is not required for alum adjuvanticity. FASEB J. 26, 1272\u20131279. https:\/\/doi.org\/10.1096\/fj.11-184556 (2012).","journal-title":"FASEB J."},{"key":"25605_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52687","author":"EH Kim","year":"2020","unstructured":"Kim, E. H. et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. Elife https:\/\/doi.org\/10.7554\/eLife.52687 (2020).","journal-title":"Elife"},{"key":"25605_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nm.2403","volume":"17","author":"T Marichal","year":"2011","unstructured":"Marichal, T. et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 17, 996\u20131002. https:\/\/doi.org\/10.1038\/nm.2403 (2011).","journal-title":"Nat. Med."},{"key":"25605_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1084\/jem.20071087","volume":"205","author":"M Kool","year":"2008","unstructured":"Kool, M. et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205, 869\u2013882. https:\/\/doi.org\/10.1084\/jem.20071087 (2008).","journal-title":"J. Exp. Med."},{"key":"25605_CR14","doi-asserted-by":"publisher","first-page":"21095","DOI":"10.1073\/pnas.1319784110","volume":"110","author":"M Vono","year":"2013","unstructured":"Vono, M. et al. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc. Natl. Acad. Sci. U.S.A. 110, 21095\u201321100. https:\/\/doi.org\/10.1073\/pnas.1319784110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"25605_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/j.1524-4725.2012.02547.x","volume":"38","author":"MS Lolis","year":"2012","unstructured":"Lolis, M. S. & Goldberg, D. J. Radiofrequency in cosmetic dermatology: A review. Dermatol. Surg. 38, 1765\u20131776. https:\/\/doi.org\/10.1111\/j.1524-4725.2012.02547.x (2012).","journal-title":"Dermatol. Surg."},{"key":"25605_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4261\/1305-3825.DIR.5168-11.1","volume":"18","author":"S Tatli","year":"2012","unstructured":"Tatli, S., Tapan, U., Morrison, P. R. & Silverman, S. G. Radiofrequency ablation: Technique and clinical applications. Diagn. Interv. Radiol. 18, 508\u2013516. https:\/\/doi.org\/10.4261\/1305-3825.DIR.5168-11.1 (2012).","journal-title":"Diagn. Interv. Radiol."},{"key":"25605_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/ern.09.153","volume":"10","author":"M Soloman","year":"2010","unstructured":"Soloman, M., Mekhail, M. N. & Mekhail, N. Radiofrequency treatment in chronic pain. Expert Rev. Neurother. 10, 469\u2013474. https:\/\/doi.org\/10.1586\/ern.09.153 (2010).","journal-title":"Expert Rev. Neurother."},{"key":"25605_CR18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/vaccines9121382","volume":"9","author":"Y Li","year":"2021","unstructured":"Li, Y., Li, Z., Zhao, Y. & Chen, X. Potentiation of recombinant NP and M1-induced cellular immune responses and protection by physical radiofrequency adjuvant. Vaccines 9, 1382. https:\/\/doi.org\/10.3390\/vaccines9121382 (2021).","journal-title":"Vaccines"},{"key":"25605_CR19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101703R","volume":"36","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination. FASEB J. 36, e22182. https:\/\/doi.org\/10.1096\/fj.202101703R (2022).","journal-title":"FASEB J."},{"key":"25605_CR20","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1038\/s41467-018-06151-y","volume":"9","author":"Y Cao","year":"2018","unstructured":"Cao, Y. et al. Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant. Nat. Commun. 9, 3695. https:\/\/doi.org\/10.1038\/s41467-018-06151-y (2018).","journal-title":"Nat. Commun."},{"key":"25605_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.antiviral.2018.06.004","volume":"156","author":"EJ Ko","year":"2018","unstructured":"Ko, E. J. et al. MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine. Antiviral Res. 156, 107\u2013115. https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.004 (2018).","journal-title":"Antiviral Res."},{"key":"25605_CR22","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","volume":"75","author":"TM Tumpey","year":"2001","unstructured":"Tumpey, T. M., Renshaw, M., Clements, J. D. & Katz, J. M. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol. 75, 5141\u20135150. https:\/\/doi.org\/10.1128\/JVI.75.11.5141-5150.2001 (2001).","journal-title":"J. Virol."},{"key":"25605_CR23","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1016\/j.vaccine.2010.06.075","volume":"28","author":"C Gravel","year":"2010","unstructured":"Gravel, C. et al. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine 28, 5774\u20135784. https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.075 (2010).","journal-title":"Vaccine"},{"key":"25605_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1911s42","author":"R Cottey","year":"2001","unstructured":"Cottey, R., Rowe, C. A. & Bender, B. S. Influenza virus. Curr. Protoc. Immunol. https:\/\/doi.org\/10.1002\/0471142735.im1911s42 (2001).","journal-title":"Curr. Protoc. Immunol."},{"key":"25605_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144627","author":"Z Li","year":"2021","unstructured":"Li, Z., Cao, Y., Li, Y., Zhao, Y. & Chen, X. Vaccine delivery alerts innate immune systems for more immunogenic vaccination. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.144627 (2021).","journal-title":"JCI Insight"},{"key":"25605_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c01028","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Li, Z., Voyer, J., Li, Y. & Chen, X. Flagellin\/virus-like particle hybrid platform with high immunogenicity, safety, and versatility for vaccine development. ACS Appl. Mater. Interfaces https:\/\/doi.org\/10.1021\/acsami.2c01028 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"25605_CR27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/cid\/ciz411","volume":"69","author":"EA Belongia","year":"2019","unstructured":"Belongia, E. A. & McLean, H. Q. Influenza vaccine effectiveness: Defining the H3N2 problem. Clin. Infect. Dis. 69, 1817\u20131823. https:\/\/doi.org\/10.1093\/cid\/ciz411 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"25605_CR28","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1073\/pnas.1519690113","volume":"113","author":"HI Nakaya","year":"2016","unstructured":"Nakaya, H. I. et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc. Natl. Acad. Sci. U.S.A. 113, 1853\u20131858. https:\/\/doi.org\/10.1073\/pnas.1519690113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"25605_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4161\/hv.18445","volume":"8","author":"G Della Cioppa","year":"2012","unstructured":"Della Cioppa, G. et al. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 ((R)) adjuvant: Results from a dose-finding clinical trial in older adults. Hum. Vaccines Immunother. 8, 216\u2013227. https:\/\/doi.org\/10.4161\/hv.18445 (2012).","journal-title":"Hum. Vaccines Immunother."},{"key":"25605_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jconrel.2011.07.029","volume":"157","author":"A Bershteyn","year":"2012","unstructured":"Bershteyn, A. et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J. Control. Release 157, 354\u2013365. https:\/\/doi.org\/10.1016\/j.jconrel.2011.07.029 (2012).","journal-title":"J. Control. Release"},{"key":"25605_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fimmu.2015.00207","volume":"6","author":"KK Yam","year":"2015","unstructured":"Yam, K. K. et al. AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB\/c mice. Front. Immunol. 6, 207. https:\/\/doi.org\/10.3389\/fimmu.2015.00207 (2015).","journal-title":"Front. Immunol."},{"key":"25605_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fimmu.2016.00159","volume":"7","author":"SK Calderwood","year":"2016","unstructured":"Calderwood, S. K., Gong, J. & Murshid, A. Extracellular HSPs: The complicated roles of extracellular HSPs in immunity. Front. Immunol. 7, 159. https:\/\/doi.org\/10.3389\/fimmu.2016.00159 (2016).","journal-title":"Front. Immunol."},{"key":"25605_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/1389203715666140331113057","volume":"15","author":"A De Maio","year":"2014","unstructured":"De Maio, A. Extracellular Hsp70: Export and function. Curr. Protein Pept. Sci. 15, 225\u2013231. https:\/\/doi.org\/10.2174\/1389203715666140331113057 (2014).","journal-title":"Curr. Protein Pept. Sci."},{"key":"25605_CR34","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1096\/fj.201801095R","volume":"33","author":"JA Gelfand","year":"2019","unstructured":"Gelfand, J. A. et al. A pilot clinical trial of a near-infrared laser vaccine adjuvant: Safety, tolerability, and cutaneous immune cell trafficking. FASEB J. 33, 3074\u20133081. https:\/\/doi.org\/10.1096\/fj.201801095R (2019).","journal-title":"FASEB J."},{"key":"25605_CR35","doi-asserted-by":"publisher","first-page":"e82899","DOI":"10.1371\/journal.pone.0082899","volume":"8","author":"S Kashiwagi","year":"2013","unstructured":"Kashiwagi, S. et al. Near-infrared laser adjuvant for influenza vaccine. PLoS ONE 8, e82899. https:\/\/doi.org\/10.1371\/journal.pone.0082899 (2013).","journal-title":"PLoS ONE"},{"key":"25605_CR36","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1586\/14760584.2013.844070","volume":"12","author":"X Chen","year":"2013","unstructured":"Chen, X., Wang, J., Shah, D. & Wu, M. X. An update on the use of laser technology in skin vaccination. Expert. Rev. Vaccines 12, 1313\u20131323. https:\/\/doi.org\/10.1586\/14760584.2013.844070 (2013).","journal-title":"Expert. Rev. Vaccines"},{"key":"25605_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1586\/erv.11.112","volume":"10","author":"X Chen","year":"2011","unstructured":"Chen, X. & Wu, M. X. Laser vaccine adjuvant for cutaneous immunization. Expert. Rev. Vaccines 10, 1397\u20131403. https:\/\/doi.org\/10.1586\/erv.11.112 (2011).","journal-title":"Expert. Rev. Vaccines"},{"key":"25605_CR38","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.4161\/hv.28840","volume":"10","author":"S Kashiwagi","year":"2014","unstructured":"Kashiwagi, S., Brauns, T., Gelfand, J. & Poznansky, M. C. Laser vaccine adjuvants History, progress, and potential. Hum. Vaccine Immunother. 10, 1892\u20131907. https:\/\/doi.org\/10.4161\/hv.28840 (2014).","journal-title":"Hum. Vaccine Immunother."},{"key":"25605_CR39","doi-asserted-by":"publisher","first-page":"e13776","DOI":"10.1371\/journal.pone.0013776","volume":"5","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS ONE 5, e13776. https:\/\/doi.org\/10.1371\/journal.pone.0013776 (2010).","journal-title":"PLoS ONE"},{"key":"25605_CR40","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4049\/jimmunol.1601873","volume":"199","author":"K Morse","year":"2017","unstructured":"Morse, K. et al. Near-infrared 1064 nm laser modulates migratory dendritic cells to augment the immune response to intradermal influenza vaccine. J. Immunol. 199, 1319\u20131332. https:\/\/doi.org\/10.4049\/jimmunol.1601873 (2017).","journal-title":"J. Immunol."},{"key":"25605_CR41","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/1078-0432.ccr-11-2654","volume":"18","author":"X Chen","year":"2012","unstructured":"Chen, X., Zeng, Q. & Wu, M. X. Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination. Clin. Cancer Res. 18, 2240\u20132249. https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-2654 (2012).","journal-title":"Clin. Cancer Res."},{"key":"25605_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","volume":"31","author":"X Chen","year":"2012","unstructured":"Chen, X., Pravetoni, M., Bhayana, B., Pentel, P. R. & Wu, M. X. High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine 31, 159\u2013164. https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.069 (2012).","journal-title":"Vaccine"},{"key":"25605_CR43","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1038\/ncomms5447","volume":"5","author":"J Wang","year":"2014","unstructured":"Wang, J., Shah, D., Chen, X., Anderson, R. R. & Wu, M. X. A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat. Commun. 5, 4447. https:\/\/doi.org\/10.1038\/ncomms5447 (2014).","journal-title":"Nat. Commun."},{"key":"25605_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02156-17","author":"PP Lopes","year":"2018","unstructured":"Lopes, P. P. et al. Laser adjuvant-assisted peptide vaccine promotes skin mobilization of dendritic cells and enhances protective CD8(+) TEM and TRM cell responses against herpesvirus infection and disease. J. Virol. https:\/\/doi.org\/10.1128\/jvi.02156-17 (2018).","journal-title":"J. Virol."},{"key":"25605_CR45","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1073\/pnas.1500408112","volume":"112","author":"J Wang","year":"2015","unstructured":"Wang, J., Li, B. & Wu, M. X. Effective and lesion-free cutaneous influenza vaccination. Proc. Natl. Acad. Sci. U.S.A. 112, 5005\u20135010. https:\/\/doi.org\/10.1073\/pnas.1500408112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"25605_CR46","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1016\/j.vaccine.2005.02.027","volume":"23","author":"A Tezel","year":"2005","unstructured":"Tezel, A., Paliwal, S., Shen, Z. & Mitragotri, S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23, 3800\u20133807. https:\/\/doi.org\/10.1016\/j.vaccine.2005.02.027 (2005).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25605-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25605-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25605-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:15:07Z","timestamp":1670526907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25605-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25605"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25605-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21249"}}